Physicochemical and Biological Characterization of RTXM83, a New Rituximab Biosimilar
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Physicochemical and Biological Characterization of RTXM83, a New Rituximab Biosimilar
Authors
Keywords
-
Journal
BIODRUGS
Volume 33, Issue 3, Pages 307-319
Publisher
Springer Science and Business Media LLC
Online
2019-03-29
DOI
10.1007/s40259-019-00349-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach
- (2018) Myrna Candelaria et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Comparability study of Rituximab originator and follow-on biopharmaceutical
- (2017) Othman Montacir et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study
- (2017) Neh Nupur et al. mAbs
- Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab
- (2016) Hector A. Cuello et al. BIODRUGS
- Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)
- (2016) Juyong Hong et al. mAbs
- The Regulation of Biosimilars in Latin America
- (2016) Ricardo Garcia et al. Current Rheumatology Reports
- Advances in Therapeutic Fc Engineering – Modulation of IgG-Associated Effector Functions and Serum Half-life
- (2016) Abhishek Saxena et al. Frontiers in Immunology
- Analytical characterization of biosimilar antibodies and Fc-fusion proteins
- (2013) Alain Beck et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies
- (2012) Yi Du et al. mAbs
- Acceptable changes in quality attributes of glycosylated biopharmaceuticals
- (2011) Martin Schiestl et al. NATURE BIOTECHNOLOGY
- Charge variants in IgG1
- (2010) Leslie A. Khawli et al. mAbs
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
- (2010) Darius Ghaderi et al. NATURE BIOTECHNOLOGY
- Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development
- (2010) John den Engelsman et al. PHARMACEUTICAL RESEARCH
- Rituximab: Mechanism of Action
- (2010) George J. Weiner SEMINARS IN HEMATOLOGY
- Optimal and consistent protein glycosylation in mammalian cell culture
- (2009) P. Hossler et al. GLYCOBIOLOGY
- C-terminal lysine variants in fully human monoclonal antibodies: Investigation of test methods and possible causes
- (2008) Lawrence W. Dick et al. BIOTECHNOLOGY AND BIOENGINEERING
- Applications of CE SDS gel in development of biopharmaceutical antibody-based products
- (2008) Richard R. Rustandi et al. ELECTROPHORESIS
- A review of the current use of rituximab in autoimmune diseases
- (2008) Hakan M. Gürcan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs
- (2008) Sandipan Sinha et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- Heterogeneity of Monoclonal Antibodies
- (2007) Hongcheng Liu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started